BTAI
1.10 USD
-1.89%
Today
-0.95%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
BioXcel Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
35.76M
Avg Daily Volume
5.89M
52 Week High
8.08 USD
52 Week Low
1.17 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its neuroscience candidate, BXCL501, which is an investigational, proprietary, orally dissolving film formulation of dexmedetomidine in Phase 3 trial for the treatment of agitation associated with bipolar disorders, schizophrenia, and Alzheimer's disease, as well as opioid use disorder, alcohol use disorder with comorbid post-traumatic stress disorder, and acute stress disorder; and its immune-oncology candidate, BXCL701, which is an investigational oral innate immune activator that has completed Phase 1b/2a trial for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. In addition, the company engages in the development of BXCL502 for the treatment of stress-related neuropsychiatric symptoms in dementia and other stress-related disorders; BXCL503, a drug candidate to target apathy in dementia; and BXCL504, which has the potential to address apathy and aggression in dementia. The company has collaborations with Columbia University, Yale University Medical School, and University of North Carolina for the development of BXCL501. BioXcel Therapeutics, Inc. was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Top News
AmAirlines
-0.53%
AbbottLabs
-2.35%
Aehr.Systems
+1.44%
AmgenInc
+0.94%
Amarin
-0.91%
Apollo
-2.49%
AxonEnterprise
-1.56%
BOAmerica
-0.13%
Beyond.Inc
-1.68%
BookingHld
-1.76%
BioXcel
-0.95%
Blackstone
-1.66%
Coeur
+2.59%
CFIndustries
+1.73%
Chegg
-6.02%
Chewy
-2.86%
Clean.Spark
-2.25%
Coinbase
-1.15%
Chevron
-0.53%
Delta
-0.16%
Deere
-1.20%
DR_Horton
+0.35%
Devon
+0.23%
ElancoAnimal
-1.50%
Elevance-Health-Inc
-2.02%
Expedia
-1.01%
Freeport_Mcmoran
+2.43%
GATX_Corp
+1.37%
Greenbrier
-2.34%
GileadSci
-2.26%
GoldmanSachs
+0.80%
HimsandHers.Inc
-0.41%
Hecla.Mining
+0.73%
Humana
-2.52%
IDEXXLab
-3.76%
Insmed
-3.03%
JBHunt
+0.86%
JPMorgan
+0.09%
KKR&Co
-1.65%
Lennar
+0.51%
Levi.Strauss
+0.00%
Southwest
-1.74%
Mosaic
-2.06%
MicroStrategy
-0.76%
NorwegianCruise
+1.06%
NewmontM
+2.35%
Novavax
-5.52%
Opko
-1.74%
Occidental
+0.00%
PulteGroup
-1.54%
ProQR.Therapeutics
-6.19%
SouthernCopper
+2.32%
Scorpio.Tankers
-2.29%
TollBrothers
-0.04%
UnitySoftware
+0.33%
UnitedCon
-1.32%
UnitedHlt
-0.66%
ViaSat
+0.92%
Westinghouse
-1.21%
WellsFargo
-0.61%
ExxonMobil
-1.24%
ZoetisInc
-1.82%
BUZZ-U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
reuters.com
2d ago
AmAirlines
-0.53%
AbbottLabs
-2.35%
Aehr.Systems
+1.44%
AmgenInc
+0.94%
Amarin
-0.91%
Apollo
-2.49%
AxonEnterprise
-1.56%
BOAmerica
-0.13%
Beyond.Inc
-1.68%
BookingHld
-1.76%
BioXcel
-0.95%
Blackstone
-1.66%
Coeur
+2.59%
CFIndustries
+1.73%
Clean.Spark
-2.25%
Coinbase
-1.15%
Chevron
-0.53%
Delta
-0.16%
Deere
-1.20%
Devon
+0.23%
ElancoAnimal
-1.50%
Elevance-Health-Inc
-2.02%
Expedia
-1.01%
Freeport_Mcmoran
+2.43%
GATX_Corp
+1.37%
Greenbrier
-2.34%
GileadSci
-2.26%
GoldmanSachs
+0.80%
Hecla.Mining
+0.73%
Humana
-2.52%
IDEXXLab
-3.76%
Insmed
-3.03%
JBHunt
+0.86%
JPMorgan
+0.09%
KKR&Co
-1.65%
Levi.Strauss
+0.00%
Southwest
-1.74%
Mosaic
-2.06%
MicroStrategy
-0.76%
NorwegianCruise
+1.06%
NewmontM
+2.35%
Novavax
-5.52%
Opko
-1.74%
Occidental
+0.00%
SouthernCopper
+2.32%
Scorpio.Tankers
-2.29%
UnitySoftware
+0.33%
UnitedCon
-1.32%
ViaSat
+0.92%
Westinghouse
-1.21%
WellsFargo
-0.61%
ExxonMobil
-1.24%
ZoetisInc
-1.82%
BUZZ-U.S. STOCKS ON THE MOVE-Delta, Levi's, banks
reuters.com
2d ago
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
tradingview.com
2d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
